Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.72 USD | +2.14% | +6.31% | +22.55% |
04-29 | Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER | CI |
04-11 | Collegium Pharmaceutical to Redeem $26.35 Million of Senior Notes | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.55% | 1.24B | |
+33.25% | 699B | |
+27.19% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.66% | 236B | |
+4.47% | 198B | |
-11.00% | 194B | |
-5.59% | 154B |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Collegium Pharmaceutical : HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $28 From $33, Maintains Buy Rating